Table 2. Laboratory data at the time of admission for the two groups of COVID-19 infected patients.
| Parameter | Patients with no AKI | Patients with AKI | P value |
|---|---|---|---|
| Median (IQR) | Median (IQR) | ||
| Kidney function | |||
| eGFR (ml/min) | 60 (0) | 57 (24) | <0.001 |
| Creatinine (μmol/L) | 68 (81) | 117 (88) | <0.001 |
| Urea (mmol/L) | 4.6 (2.1) | 9.2 (7.5) | <0.001 |
| Uric Acid (μmol/L) | 281 (121) | 383 (206) | <0.001 |
| Na+ (mmol/L) | 136 (5) | 135 (7) | <0.05 |
| K+ (mmol/L) | 4.4 (0.6) | 4.6 (0.9) | <0.05 |
| HCO3- (mmol/L) | 23 (4) | 21 (5) | <0.001 |
| Erythropoiesis and Leukopoiesis | |||
| Hb (g/dl) | 14.1 (2.6) | 12.9 (3.3) | <0.001 |
| Leukocytes (x103/μl) | 5.44 (3.09) | 6.47 (5.16) | <0.001 |
| Lymphocytes (x103/μl) | 1166 (980) | 948 (749) | <0.001 |
| Clotting and fibrinolysis | |||
| Platelets (x103/μL) | 218 (108) | 201(95) | <0.05 |
| PT (sec) | 14.9 (1.6) | 14.8 (1.8) | n.s. |
| INR | 1.00 (0.12) | 1.05 (0.14) | <0.01 |
| D. Dimer | 0.48 (1.00) | 1.04 (2.00) | <0.001 |
| Cardiac markers | |||
| CK (IU/L) | 152 (340) | 244 (413) | <0.01 |
| CKMB (IU/L) | 27 (20) | 30 (22) | <0.05 |
| Troponin T (μg/L) | 0.00 (0.00) | 0.00 (0.12) | <0.001 |
| ProBNP (pg/ml) | 41 (137) | 304 (940) | <0.001 |
| Inflammatory markers | |||
| ESR (mm/h) | 37 (34) | 50 (35) | <0.001 |
| CRP (mg/L) | 47 (105) | 115 (132) | <0.001 |
| Ferritin (ng/ml) | 704 (1072) | 940 (1234) | <0.01 |
| PCT (ng/ml) | 0.11 (0.10) | 0.4 (1.12) | <0.001 |
| Liver function | |||
| Albumin (g/L) | 39 (7) | 35 (6) | <0.001 |
| ALT (IU/L) | 34 (38) | 29 (26) | <0.01 |
| AST (IU/L) | 41 (31) | 44 (43) | n.s. |
| GGT (IU/L) | 54 (72) | 51 (67) | n.s. |
| ALP (IU/L) | 70 (33) | 76 (39) | n.s. |